Inogen (INGN) Competitors

Inogen (NASDAQ:INGN) and Invacare (NYSE:IVC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, valuation, profitability, media sentiment, analyst recommendations, earnings, institutional ownership and dividends.

Is INGN or IVC more profitable?

Invacare has a net margin of -9.99% compared to Inogen's net margin of -15.89%. Inogen's return on equity of -27.38% beat Invacare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inogen	-15.89%	-27.38%	-16.77%
Invacare	-9.99%	-37.76%	-7.18%

Does the media prefer INGN or IVC?

In the previous week, Inogen had 2 more articles in the media than Invacare. MarketBeat recorded 2 mentions for Inogen and 0 mentions for Invacare. Inogen's average media sentiment score of 0.88 beat Invacare's score of 0.62 indicating that Inogen is being referred to more favorably in the media.

Company	Overall Sentiment
Inogen	Positive
Invacare	Positive

Which has preferable earnings and valuation, INGN or IVC?

Invacare has higher revenue and earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than Invacare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inogen	$315.66M	0.71	-$102.45M	-$2.25	-4.17
Invacare	$872.46M	0.00	-$45.56M	-$2.18	N/A

Do insiders & institutionals have more ownership in INGN or IVC?

89.9% of Inogen shares are owned by institutional investors. Comparatively, 59.9% of Invacare shares are owned by institutional investors. 1.0% of Inogen shares are owned by company insiders. Comparatively, 6.9% of Invacare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has more risk & volatility, INGN or IVC?

Inogen has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500. Comparatively, Invacare has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500.

Do analysts rate INGN or IVC?

Inogen presently has a consensus target price of $7.00, indicating a potential downside of 25.37%. Given Invacare's higher possible upside, analysts plainly believe Invacare is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Invacare	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the MarketBeat Community prefer INGN or IVC?

Inogen received 122 more outperform votes than Invacare when rated by MarketBeat users. Likewise, 69.48% of users gave Inogen an outperform vote while only 51.26% of users gave Invacare an outperform vote.

Company	Underperform	Outperform
Inogen	Outperform Votes 387 69.48%	Underperform Votes 170 30.52%
Invacare	Outperform Votes 265 51.26%	Underperform Votes 252 48.74%

Summary

Inogen beats Invacare on 9 of the 17 factors compared between the two stocks.